Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term open-label phase 3 study of TPN171H tablets in men with erectile dysfunction
CTR20240721Phase 3Completed
- Sponsor
- Shanghai Institute of Materia Medica
- Start
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of TPN171H in erectile dysfunction (ED), sponsored by Shanghai Institute of Materia Medica. Started Mar 2024; status: completed.
02
Drugs
TPN171H
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on CTR20240721.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20240721.